Ftse Mib
33.114,24
-0,22%
DAX
18.235,45
0,17%
S&P 500
5.472,55
-0,19%
NASDAQ
17.823,62
-0,20%
Bitcoin
60.708,46
-1,46%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ligand Pharmaceuticals Incorporated (LGND) Ligand Pharmaceuticals Incorporated (LGND) Notizie

Ligand Pharmaceuticals Incorporated

LGND
83,735
1,41 (1,71%)
Ultimo aggiornamento: 20:29:01
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202422:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/5/202422:03EDGAR2Form 8-K - Current report
18/5/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202423:45EDGAR2Form 144 - Report of proposed sale of securities
16/5/202423:39EDGAR2Form 144 - Report of proposed sale of securities
16/5/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202400:01EDGAR2Form 144 - Report of proposed sale of securities
15/5/202420:45EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
15/5/202401:42EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:11EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/3/202419:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:12EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202400:05EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:43EDGAR2Form 144 - Report of proposed sale of securities
27/2/202413:24EDGAR2Form 8-K - Current report
17/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202412:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202421:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202401:30GLOBEHenlius and Sermonix Announce Strategic Collaboration and..
05/1/202423:40DJNLigand Pharmaceuticals Gets FDA OK for Viral Skin Infection..
04/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202321:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202321:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:25EDGAR2Form 8-K - Current report
01/12/202314:20GLOBEPalvella Therapeutics and Ligand Pharmaceuticals Expand..
28/11/202315:01GLOBESermonix Pharmaceuticals Announces Five Abstracts Accepted..
10/11/202303:48EDGAR2Form 8-K/A - Current report: [Amend]
09/11/202323:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:08EDGAR2Form 8-K - Current report
06/11/202315:00GLOBESermonix Pharmaceuticals Announces JCO Precision Oncology..
18/10/202315:03EDGAR2Form 8-K - Current report
18/10/202314:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
03/10/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202315:00GLOBESermonix Pharmaceuticals Shares Results of EQUALS 2 Survey..
27/9/202314:38EDGAR2Form 8-K - Current report
26/9/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202323:26EDGAR2Form 8-K - Current report
14/8/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 82,72 Min: 81,86 Max: 83,87
Chiusura: 82,33

La tua Cronologia

NASDAQ
LGND
Ligand Pharmaceuticals
BIT
UC8364
Unicredit Bank
EU
FR001400OSW6
FCT Credit Agricole Habi...
BIT
UC6123
Unicredit Bank
BOV
BBDC4M
BRADESCO PN
BIT
UB517B
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network